β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Growth
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Growth | Gross Profit Growth | EBIT Growth | Operating Income Growth | Net Income Growth | EPS Growth | EPS Diluted Growth | Weighted Average Shares Growth | Weighted Average Shares Diluted Growth | Dividends per Share Growth | Operating Cash Flow Growth | Free Cash Flow Growth | Ten Y Revenue Growth Per Share | Five Y Revenue Growth Per Share | Three Y Revenue Growth Per Share | Ten Y Operating CF Growth Per Share | Five Y Operating CF Growth Per Share | Three Y Operating CF Growth Per Share | Ten Y Net Income Growth Per Share | Five Y Net Income Growth Per Share | Three Y Net Income Growth Per Share | Ten Y Shareholders Equity Growth Per Share | Five Y Shareholders Equity Growth Per Share | Three Y Shareholders Equity Growth Per Share | Ten Y Dividend per Share Growth Per Share | Five Y Dividend per Share Growth Per Share | Three Y Dividend per Share Growth Per Share | Receivables Growth | Inventory Growth | Asset Growth | Book Value per Share Growth | Debt Growth | R&D Expense Growth | SGA Expenses Growth |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03 | 0.0821 | 0.0759 | 13.4728 | 13.4728 | 2.7823 | 2.8758 | 2.8758 | -0.0497 | -0.0497 | -0.0082 | 0.9557 | 3.9336 | 1.2769 | 0.4235 | 0.3126 | 2.1373 | 1.4367 | 1.0312 | 0.5146 | -0.0801 | 3.2325 | 0.8933 | 0.1607 | 0.0796 | 0.6149 | 0.2389 | 0.1522 | -0.1551 | 0.0974 | 0.0344 | 0.0956 | -0.0289 | -0.1018 | -0.0491 |
2023-03 | 0.0479 | 0.0606 | -1.0861 | -1.0861 | -1.5491 | -1.5667 | -1.5676 | -0.0309 | -0.0325 | 0.0846 | -0.1932 | 0.231 | 1.5517 | 0.3013 | 0.1901 | 3.0682 | -0.0904 | -0.0419 | -1.9852 | -1.4447 | -1.652 | 0.9384 | 0.0789 | 0.0 | 0.621 | 0.2524 | 0.2514 | 0.076 | 0.0595 | -0.0843 | -0.1015 | 0.0994 | 0.0727 | 0.1391 |
2022-03 | 0.0667 | 0.0343 | 1.7781 | 1.7781 | 2.985 | 2.9807 | 2.9841 | 7.0E-4 | 1.0E-4 | 0.0711 | 0.1864 | -0.32 | 1.5358 | 0.3726 | 0.1559 | 1.3354 | 3.3585 | 0.4221 | 0.7283 | 0.286 | -0.1345 | 1.2307 | 0.3688 | 0.1787 | 0.5014 | 0.1451 | 0.1517 | 0.0374 | -0.1066 | 0.1432 | 0.0961 | 2.2458 | 0.0939 | 0.0621 |
2021-03 | 0.0333 | 0.0317 | -0.6148 | -0.6148 | -0.7108 | -0.7109 | -0.7108 | 7.0E-4 | 3.0E-4 | 0.0771 | -0.0285 | -0.5115 | 1.4087 | 0.3239 | 0.1289 | 1.3355 | 0.7846 | -0.0784 | -0.6576 | -0.8674 | -0.8029 | 1.103 | 0.2254 | 0.0948 | 0.7573 | 0.1679 | 0.078 | 0.1033 | 0.1783 | -0.0156 | 0.014 | -0.1769 | 0.033 | 0.0844 |
2020-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more financial growth data for Santen Pharmaceutical!
Sign up for free or log inπ Get insights from "The Checklist Value Investor β A Smarter Way to Pick Stocks" now!